Stock UniverseDerived research view · source repositories remain read-only

Coherus Oncology, Inc. (CHRS)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
22.26
Global Rank
3056
Market Cap
249.62M
Latest Close
1.45
RS Composite
-16.89% · G#2488

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-17.14%
3M
-20.33%
6M
18.85%
1Y
81.93%
3Y
-64.55%
5Y
-88.98%
10Y
-92.23%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 896.89K · 30-day average: 1.23M · Max drawdown over stored range: -97.88%

Research Snapshot

Relative Strength vs SPX

RS Composite-16.89%
20D RS-18.25%
60D RS-27.51%
120D RS-5.60%
Global RS Rank2488 · 25.84% percentile
Watch+Speculative RS Rank1538 · 26.66% percentile
Group ScopeWatch+Speculative
Primary RS Rank265 · 42.14% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank363 / 701
Primary Percentile48.36
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for CHRS.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue475.824326.551211.042257.244266.9642.172
Revenue Growth (YoY)33.632%-31.371%-35.372%21.892%3.777%59.809%
Gross Profit438.157268.96140.95998.252149.407
Operating Income156.319-263.858-256.88-193.199-94.367
Free Cash Flow146.914-38.721-241.124-174.884-20.44-138.513
Free Cash Flow Per Share1.76-0.513-3.106-1.857-0.178-1.182421993914692
EPS (Diluted) GAAP1.623522-3.805187-3.759999-2.530.248853
EPS Growth31.994%4100%4100%4100%4100%472.0%
EPS Non-GAAP
Gross Margin92.084%82.364%66.792%38.194%55.966%67.2437%
Operating Margin32.852%-80.801%-121.72%-75.103%-35.349%-429.5125%
Profit Margin27.793%-87.919%-138.245%-92.477%10.678%398.4255%
Free Cash Flow Margin30.876%-11.858%-114.254%-67.984%-7.657%-328.4478%
Shares Outstanding (Diluted)83.491975.449677.6394.1626114.8305117.1435
Shares Change (YoY)14.082%-9.632%2.89%21.297%21.949%2.261%

SEC Quarterly Fundamentals

No processed quarterly rows for CHRS.